Benucci, M.; Bardelli, M.; Cazzato, M.; Laurino, E.; Bartoli, F.; Damiani, A.; Li Gobbi, F.; Panaccione, A.; Di Cato, L.; Niccoli, L.;
et al. ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice. J. Pers. Med. 2023, 13, 1303.
https://doi.org/10.3390/jpm13091303
AMA Style
Benucci M, Bardelli M, Cazzato M, Laurino E, Bartoli F, Damiani A, Li Gobbi F, Panaccione A, Di Cato L, Niccoli L,
et al. ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice. Journal of Personalized Medicine. 2023; 13(9):1303.
https://doi.org/10.3390/jpm13091303
Chicago/Turabian Style
Benucci, Maurizio, Marco Bardelli, Massimiliano Cazzato, Elenia Laurino, Francesca Bartoli, Arianna Damiani, Francesca Li Gobbi, Anna Panaccione, Luca Di Cato, Laura Niccoli,
and et al. 2023. "ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice" Journal of Personalized Medicine 13, no. 9: 1303.
https://doi.org/10.3390/jpm13091303
APA Style
Benucci, M., Bardelli, M., Cazzato, M., Laurino, E., Bartoli, F., Damiani, A., Li Gobbi, F., Panaccione, A., Di Cato, L., Niccoli, L., Frediani, B., Mosca, M., Guiducci, S., & Cantini, F.
(2023). ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice. Journal of Personalized Medicine, 13(9), 1303.
https://doi.org/10.3390/jpm13091303
